{"id":11351,"date":"2022-07-01T20:34:20","date_gmt":"2022-07-02T00:34:20","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/immunotherapy-for-blood-cancers-updates-from-the-field-with-hearn-jay-cho-m-d-ph-d\/"},"modified":"2022-07-14T16:09:28","modified_gmt":"2022-07-14T20:09:28","slug":"immunotherapy-blood-cancer-myeloma-leukemia","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/immunotherapy-blood-cancer-myeloma-leukemia","title":{"rendered":"Immunotherapy for Blood Cancers: Updates from the Field, with Hearn Jay Cho, MD, PhD"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/pWGw-yLzfCQ\" width=\"560\"><\/iframe><\/p>\n<p>Clinical research around the world is focused on helping patients with blood cancers like leukemia, lymphoma, and multiple myeloma to benefit from a new class of cancer treatments called immunotherapy. CAR T cells, monoclonal antibodies, cancer vaccines, and checkpoint blockade are bringing patients new treatment options.<\/p>\n<p>In this webinar for patients and caregivers, Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for cancers of the blood.&nbsp;<\/p>\n<p>This webinar was recorded Tuesday, October 3, 2017. The &quot;Cancer Immunotherapy and You&quot; webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.&nbsp;<\/p>\n<p>Browse our <a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">Cancer Immunotherapy and You Webinar Series playlist<\/a> on YouTube or visit the <a href=\"\/events\/webinars\" target=\"_blank\" rel=\"noopener\">Webinars page on our website<\/a> to see other webinars in this series.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.&nbsp;<\/p>\n","protected":false},"featured_media":1414,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11351","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy for Blood Cancers Update<\/title>\n<meta name=\"description\" content=\"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy for Blood Cancers Update\" \/>\n<meta property=\"og:description\" content=\"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:09:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9e2dee1e-8d1a-48bd-b363-f3be7d891249.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Immunotherapy for Blood Cancers Update\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9e2dee1e-8d1a-48bd-b363-f3be7d891249.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia\",\"name\":\"Immunotherapy for Blood Cancers Update\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg\",\"datePublished\":\"2022-07-02T00:34:20+00:00\",\"dateModified\":\"2022-07-14T20:09:28+00:00\",\"description\":\"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunotherapy for Blood Cancers: Updates from the Field, with Hearn Jay Cho, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy for Blood Cancers Update","description":"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia","og_locale":"es_ES","og_type":"article","og_title":"Immunotherapy for Blood Cancers Update","og_description":"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0","og_url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:09:28+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9e2dee1e-8d1a-48bd-b363-f3be7d891249.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Immunotherapy for Blood Cancers Update","twitter_description":"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9e2dee1e-8d1a-48bd-b363-f3be7d891249.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia","url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia","name":"Immunotherapy for Blood Cancers Update","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg","datePublished":"2022-07-02T00:34:20+00:00","dateModified":"2022-07-14T20:09:28+00:00","description":"Dr. Hearn Jay Cho of the Mt. Sinai School of Medicine discusses the latest research and developments in cancer immunotherapy for leukemia, lymphoma, and multiple myeloma.\u00a0","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9b1d8ed4-2a56-40b5-a0ea-8e767550f2d8.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-blood-cancer-myeloma-leukemia#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Immunotherapy for Blood Cancers: Updates from the Field, with Hearn Jay Cho, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/1414"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11351"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11351"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11351"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11351"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11351"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11351"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}